KD Logo

A company insider recently sold 75,506 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]. Should You Sale?

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $1,279,661 were sold by Francis Richard D on Feb 18 ’25. At $16.95 per share, Francis Richard D sold 75,506 shares. The insider’s holdings dropped to 209,444 shares worth approximately $3.56 million following the completion of this transaction.

Also, Francis Richard D purchased 75,506 shares, netting a total of over 1,279,661 in proceeds.

Before that, Sabag Mark had sold 177,626 shares from its account. In a trade valued at $2,886,565, the See “Remarks” traded Teva- Pharmaceutical Industries Ltd. ADR shares for $16.25 each. Upon closing the transaction, the insider’s holdings decreased to 177,626 shares, worth approximately $3.48 million.

As published in a research note from Argus on July 10, 2024, Teva- Pharmaceutical Industries Ltd. ADR [TEVA] has been rated up from a Hold to a Buy and the price target has been revised to $20. Analysts at JP Morgan upgraded the stock from ‘”an Underweight”‘ to ‘”a Neutral”‘ outlook in a report released in early March. As of February 12, 2024, Piper Sandler has increased its “Neutral” rating to a “an Overweight” for TEVA. Earlier on January 23, 2024, Jefferies upgraded its rating. Their new recommendation was “a Buy” for TEVA stock which previously was a “a Hold”.

Analyzing TEVA Stock Performance

During the last five days, there has been a surge of approximately 4.04%. Over the course of the year, Teva- Pharmaceutical Industries Ltd. ADR shares have dropped approximately -22.87%. Shares of the company reached a 52-week high of $22.40 on 01/28/25 and a 52-week low of $16.08 on 02/14/25. A 50-day SMA is recorded $19.56, while a 200-day SMA reached $17.83. Nevertheless, trading volume fell to 10.12 million shares from 16.99 million shares the previous day.

Support And Resistance Levels for Teva- Pharmaceutical Industries Ltd. ADR (TEVA)

According to the 24-hour chart, there is a support level at 16.79, which, if violated, would cause prices to drop to 16.58. In the upper region, resistance lies at 17.42. The next price resistance is at 17.83. RSI (Relative Strength Index) is 37.53 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.01, which suggests the price will decrease in the coming days. Percent R is at 58.93%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular